STAT3 and malignant colon neoplasm: IL11 has not been previously associated with AHR but is known to suppress CD4+T cells mediated anti-tumor immunity, and the IL11/STAT3 inhibition increased MHC-I expression and T cell infiltration in colon cancers [40,41].